DK2225256T3 - Nye glucocorticoidreceptoragonister - Google Patents

Nye glucocorticoidreceptoragonister

Info

Publication number: DK2225256T3
Authority: DK; Denmark
Prior art keywords: receptor agonists; glucocorticoid receptor; novel glucocorticoid; novel; agonists
Prior art date: 2007-11-30

Application number

DK08854982.9T

Other languages

English (en)

Inventor

Paul Alan Glossop

David Simon Millan

David Anthony Price

Original Assignee

Pfizer Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-30

Filing date

2008-11-17

Publication date

2013-03-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40427125&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2225256(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-11-17 Application filed by Pfizer Ltd filed Critical Pfizer Ltd

2013-03-11 Application granted granted Critical

2013-03-11 Publication of DK2225256T3 publication Critical patent/DK2225256T3/da

Links

229940124750 glucocorticoid receptor agonist Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Dermatology (AREA)
Ophthalmology & Optometry (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK08854982.9T 2007-11-30 2008-11-17 Nye glucocorticoidreceptoragonister DK2225256T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US99135407P	2007-11-30	2007-11-30
US5724108P	2008-05-30	2008-05-30
US7955508P	2008-07-10	2008-07-10
PCT/IB2008/054801 WO2009069032A2 (en)	2007-11-30	2008-11-17	Novel glucocorticoid receptor agonists

Publications (1)

Publication Number	Publication Date
DK2225256T3 true DK2225256T3 (da)	2013-03-11

Family

ID=40427125

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08854982.9T DK2225256T3 (da)	2007-11-30	2008-11-17	Nye glucocorticoidreceptoragonister

Country Status (32)

Country	Link
US (2)	US8822439B2 (da)
EP (1)	EP2225256B1 (da)
JP (1)	JP4686650B2 (da)
KR (1)	KR101295998B1 (da)
CN (1)	CN101878221B (da)
AP (1)	AP2010005267A0 (da)
AR (1)	AR069490A1 (da)
AU (1)	AU2008331187B2 (da)
BR (1)	BRPI0820447A2 (da)
CA (1)	CA2706180C (da)
CL (1)	CL2008003549A1 (da)
CO (1)	CO6280401A2 (da)
CR (1)	CR11393A (da)
DK (1)	DK2225256T3 (da)
DO (1)	DOP2010000161A (da)
EA (1)	EA201070535A1 (da)
EC (1)	ECSP10010209A (da)
ES (1)	ES2399945T3 (da)
GT (1)	GT201000153A (da)
IL (1)	IL205356A0 (da)
MA (1)	MA31867B1 (da)
MX (1)	MX2010005861A (da)
NI (1)	NI201000090A (da)
NZ (1)	NZ585434A (da)
PA (1)	PA8805801A1 (da)
PE (1)	PE20091072A1 (da)
SV (1)	SV2010003580A (da)
TN (1)	TN2010000230A1 (da)
TW (1)	TW200930378A (da)
UY (1)	UY31496A1 (da)
WO (1)	WO2009069032A2 (da)
ZA (1)	ZA201003439B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9845512B2 (en) *	2010-01-15	2017-12-19	Rigel Pharmaceuticals, Inc.	Screening assay employing Dex and GDF8
TW201139369A (en)	2010-02-05	2011-11-16	Chiesi Farma Spa	Pyrrolidine derivatives
RU2013141933A (ru) *	2011-03-15	2015-03-20	КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.	Производные изоксазолидина
UA113508C2 (xx) *	2011-03-15	2017-02-10		Ізоксазолідинові похідні
FR2984325A1 (fr) *	2011-12-14	2013-06-21	Sanofi Sa	Derives de pyrazolopyridine, leur procede de preparation et leur application en therapeutique
TW201422590A (zh)	2012-09-07	2014-06-16	Abbvie Inc	雜環核激素受體調節劑
EP2935284A4 (en)	2012-12-21	2016-04-27	Abbvie Inc	HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS
US9339489B2 (en)	2013-03-15	2016-05-17	Aprecia Pharmaceuticals Company	Rapid disperse dosage form containing levetiracetam
AU2014228990B2 (en)	2013-03-15	2017-02-02	Aprecia Pharmaceuticals LLC	Rapid disperse dosage form containing levetiracetam
WO2016133967A2 (en)	2015-02-18	2016-08-25	Parion Sciences, Inc.	Sodium channel blockers for skin disorders
KR20240052871A (ko)	2016-04-27	2024-04-23	애브비 인코포레이티드	항-il-13 항체를 이용한 il-13 활성이 유해한 질환의 치료 방법
PE20190622A1 (es)	2016-06-02	2019-04-26	Abbvie Inc	Agonista del receptor de glucocorticoides e inmunoconjugados del mismo
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
WO2019071144A1 (en)	2017-10-05	2019-04-11	Fulcrum Therapeutics, Inc.	USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION
CN111465399A (zh) *	2017-12-01	2020-07-28	艾伯维公司	抗cd40抗体药物结合物
MA49796A (fr)	2017-12-01	2020-06-03	Abbvie Inc	Agoniste du récepteur des glucocorticoïdes et immunoconjugués de celui-ci
EP3768324B1 (en)	2018-03-22	2025-11-26	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods for modulating innate lymphoid cell activity, antibody drug conjugates and uses in therapy
CN109651474A (zh) *	2019-01-20	2019-04-19	湖南科瑞生物制药股份有限公司	一种16a-羟基泼尼松龙的新的制备方法
CN109575097A (zh) *	2019-01-20	2019-04-05	湖南科瑞生物制药股份有限公司	一种16a-羟基泼尼松龙产品的新的制备方法
CN109734763A (zh) *	2019-01-20	2019-05-10	湖南科瑞生物制药股份有限公司	一种16a-羟基醋酸泼尼松龙产品的制备方法
CN109575095A (zh) *	2019-01-20	2019-04-05	湖南科瑞生物制药股份有限公司	一种16a-羟基醋酸泼尼松龙的制备方法
TWI899455B (zh)	2021-03-23	2025-10-01	美商美國禮來大藥廠	糖皮質素受體激動劑
AR125084A1 (es)	2021-03-23	2023-06-07	Lilly Co Eli	Agonistas del receptor de glucocorticoides novedosos
CN117043172A (zh) *	2021-03-23	2023-11-10	伊莱利利公司	糖皮质激素受体激动剂
AR125079A1 (es)	2021-03-23	2023-06-07	Lilly Co Eli	Agonistas de receptores de glucocorticoides sustituidos con carboxi
CN117580849A (zh) *	2021-06-24	2024-02-20	江苏先声药业有限公司	甾体类化合物、其药物组合物及其应用
EP4393937A4 (en) *	2021-08-26	2025-12-31	Duality Biologics Shanghai Co Ltd	STEROID COMPOUND AND CONJUGATE OF THIS ONE
KR102835682B1 (ko) *	2022-06-16	2025-07-22	애브비 바이오테라퓨틱스 인크.	항-cd19 항체-약물 접합체

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3197469A (en) *	1958-08-06	1965-07-27	Pharmaceutical Res Products In	16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
EP1567113A4 (en)	2002-10-24	2006-11-08	G & R Pharmaceuticals Llc	ANTIMYCOTIC FORMULATIONS
WO2005044759A2 (en) *	2003-08-14	2005-05-19	Sun Pharmaceutical Industries Limited	Acetalization process for preparation of steroid compounds
WO2005028495A1 (en) *	2003-09-24	2005-03-31	Glaxo Group Limited	Anti-inflammatory glucocorticoids
GB0402797D0 (en)	2004-02-09	2004-03-10	Novartis Ag	Organic compounds
US20050227927A1 (en)	2004-03-31	2005-10-13	Robinson Cynthia B	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a glucocorticosteroid for treatment of asthma, chronic obstructive pulmonary disease or allergic rhinitis

2008
- 2008-11-17 MX MX2010005861A patent/MX2010005861A/es active IP Right Grant
- 2008-11-17 CN CN200880118275.8A patent/CN101878221B/zh not_active Expired - Fee Related
- 2008-11-17 BR BRPI0820447-0A patent/BRPI0820447A2/pt not_active IP Right Cessation
- 2008-11-17 NZ NZ585434A patent/NZ585434A/en not_active IP Right Cessation
- 2008-11-17 AP AP2010005267A patent/AP2010005267A0/en unknown
- 2008-11-17 KR KR1020107011610A patent/KR101295998B1/ko not_active Expired - Fee Related
- 2008-11-17 EA EA201070535A patent/EA201070535A1/ru unknown
- 2008-11-17 DK DK08854982.9T patent/DK2225256T3/da active
- 2008-11-17 EP EP08854982A patent/EP2225256B1/en active Active
- 2008-11-17 ES ES08854982T patent/ES2399945T3/es active Active
- 2008-11-17 CA CA2706180A patent/CA2706180C/en not_active Expired - Fee Related
- 2008-11-17 AU AU2008331187A patent/AU2008331187B2/en not_active Ceased
- 2008-11-17 JP JP2010535483A patent/JP4686650B2/ja not_active Expired - Fee Related
- 2008-11-17 WO PCT/IB2008/054801 patent/WO2009069032A2/en not_active Ceased
- 2008-11-24 US US12/276,925 patent/US8822439B2/en not_active Expired - Fee Related
- 2008-11-27 PA PA20088805801A patent/PA8805801A1/es unknown
- 2008-11-28 AR ARP080105201A patent/AR069490A1/es not_active Application Discontinuation
- 2008-11-28 TW TW097146518A patent/TW200930378A/zh unknown
- 2008-11-28 CL CL2008003549A patent/CL2008003549A1/es unknown
- 2008-11-28 PE PE2008001996A patent/PE20091072A1/es not_active Application Discontinuation
- 2008-11-28 UY UY31496A patent/UY31496A1/es not_active Application Discontinuation
2010
- 2010-04-26 IL IL205356A patent/IL205356A0/en unknown
- 2010-04-26 CR CR11393A patent/CR11393A/es not_active Application Discontinuation
- 2010-05-14 ZA ZA2010/03439A patent/ZA201003439B/en unknown
- 2010-05-21 TN TN2010000230A patent/TN2010000230A1/fr unknown
- 2010-05-24 GT GT201000153A patent/GT201000153A/es unknown
- 2010-05-25 NI NI201000090A patent/NI201000090A/es unknown
- 2010-05-26 CO CO10063356A patent/CO6280401A2/es not_active Application Discontinuation
- 2010-05-28 EC EC2010010209A patent/ECSP10010209A/es unknown
- 2010-05-28 DO DO2010000161A patent/DOP2010000161A/es unknown
- 2010-05-28 MA MA32873A patent/MA31867B1/fr unknown
- 2010-05-28 SV SV2010003580A patent/SV2010003580A/es not_active Application Discontinuation
2014
- 2014-07-23 US US14/338,434 patent/US20140336160A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20140336160A1 (en)	2014-11-13
NZ585434A (en)	2012-06-29
ZA201003439B (en)	2011-02-23
US20090227548A1 (en)	2009-09-10
US8822439B2 (en)	2014-09-02
KR101295998B1 (ko)	2013-08-13
CN101878221A (zh)	2010-11-03
CO6280401A2 (es)	2011-05-20
SV2010003580A (es)	2011-03-23
WO2009069032A2 (en)	2009-06-04
MA31867B1 (fr)	2010-11-01
KR20100074306A (ko)	2010-07-01
TW200930378A (en)	2009-07-16
ES2399945T3 (es)	2013-04-04
GT201000153A (es)	2012-04-27
HK1144821A1 (en)	2011-03-11
AU2008331187A1 (en)	2009-06-04
CA2706180A1 (en)	2009-06-04
CR11393A (es)	2010-05-19
TN2010000230A1 (fr)	2011-11-11
PA8805801A1 (es)	2009-07-23
DOP2010000161A (es)	2010-07-15
AP2010005267A0 (en)	2010-06-30
CL2008003549A1 (es)	2009-11-20
NI201000090A (es)	2010-10-04
EP2225256A2 (en)	2010-09-08
PE20091072A1 (es)	2009-07-23
BRPI0820447A2 (pt)	2015-05-26
EP2225256B1 (en)	2013-01-09
JP2011505350A (ja)	2011-02-24
JP4686650B2 (ja)	2011-05-25
AR069490A1 (es)	2010-01-27
CA2706180C (en)	2012-10-23
WO2009069032A3 (en)	2009-08-06
EA201070535A1 (ru)	2010-12-30
IL205356A0 (en)	2010-12-30
CN101878221B (zh)	2014-04-02
ECSP10010209A (es)	2010-06-29
MX2010005861A (es)	2010-06-11
AU2008331187B2 (en)	2014-04-03
UY31496A1 (es)	2009-07-17

Publication	Publication Date	Title
BRPI0820447A2 (pt)	2015-05-26	Agonistas do receptor de glicocorticóides
ATE524460T1 (de)	2011-09-15	Pyridon-gpr119-g-protein-gekoppelte rezeptoragonisten
DK2061766T3 (da)	2010-12-13	Nye forbindelser
BRPI0920237A2 (pt)	2015-12-29	agonistas do receptor aril gpr120 e suas respectivas utilizações
DK2114931T3 (da)	2012-02-13	Piperidin-GPCR-agonister
EP2490709A4 (en)	2013-05-15	PEPTIDIC GLP-2 AGONISTS
DK2114935T3 (da)	2011-10-31	Piperidin-GPCR-agonister
DK2391625T3 (da)	2013-07-01	Nye adenosinreceptorligander og anvendelser deraf
DK2401269T3 (da)	2014-04-28	Indolderivater som crth2-receptorantagonister
DK2513093T3 (da)	2014-09-29	Nye CCR2 receptor antagonister og anvendelser deraf
EP1981902A4 (en)	2009-12-23	ANTAGONISTS OF NOGO RECEPTORS
EP2350060A4 (en)	2012-07-25	Melanocortin receptor AGONISTS
ATE537157T1 (de)	2011-12-15	Substituierte phenoxy-n-alkylierte thiazoledindione als östrogenassoziierte rezeptor-alpha-modulatoren
DK2448963T3 (da)	2014-08-25	T-celle receptorer
DK2276486T3 (da)	2013-11-25	Nye substituerede imidazo-quinoliner
EP2150115A4 (en)	2011-08-03	CYCLOPROPYLPYRROLIDINOREXIN Receptor Antagonists
DE602008001416D1 (de)	2010-07-15	Sondenvorrichtung
DK2120936T3 (da)	2011-09-26	Nye fremgangsmåder
DK2081951T3 (da)	2010-08-09	Progesteron-receptorantagonister
EP2160579A4 (en)	2016-07-27	METHOD AND DEVICES FOR PROACTIVE TWIN DESTINATION CACHE MANAGEMENT
BRPI0807911A2 (pt)	2014-06-17	Agonistas de alfa2c adrenorreceptor
DK2252395T3 (da)	2021-08-09	Afsvovlingsmaterialer
IL216279A0 (en)	2012-01-31	Novel glucocorticoid receptor agonists
ATE549350T1 (de)	2012-03-15	Neuropeptid-2-rezeptor-agonisten
DK2121630T3 (da)	2012-11-12	Hurtigt dissocierende dopamin-2-receptor-antagonister